Lettie sells LGND 51.49: Ligand Pharmaceuticals (LGND) Posts Quarterly Earnings Results, Beats Estimates By $0.10 EPS
Ligand Pharmaceuticals (NASDAQ:LGND) posted its quarterly earnings results on Monday. The company reported $0.24 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.14 by $0.10, Stock Ratings Network.com reports. The company had ... ...
33 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home